A secondary analysis of the large phase III ESSENCE trial , presented by Professor Philip Newsome at this month's American Association for the Study of Liver Diseases (AASLD) meeting, has shown that semaglutide the weight loss medication widely known as Ozempic or Wegovy may also protect the liver through direct biological effects, independent of weight loss
Consumers today are more aware of how nutrition directly impacts energy levels, weight management, and overall wellness
The Link Between PMOS and Insulin Resistance Insulin resistance is defined as a condition where the body's cells become less responsive to insulin, a hormone produced by the pancreas that regulates blood sugar levels
( )
Oral tablets , like Rybelsus or the newly-approved Wegovy tablet, are great for those who prefer a pill over an injection
The results showed that semaglutide was better at lowering blood sugar than SGLT-2 inhibitors like Farxiga